HealthCap — 2005 Investments
1 investments dated 2005 · listed companies and verified rows first · show all
Oxtheraoxthera.comJul 2005 · $21M
OxThera develops a live biotherapeutic product based on oxalate-degrading bacteria to treat primary hyperoxaluria and other rare kidney diseases.
BiotechHealthtechMedical DevicesStockholm, SE
Elisabeth Lindner(Chief Operating Officer)Mats-Olof Wallin(Chief Financial Officer)Milt Allison
Co-investorsSunstone CapitalYsios Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.